Innovent Biologics Inc
OTC:IVBXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innovent Biologics Inc
OTC:IVBXF
|
CN |
|
P
|
PGG Wrightson Ltd
OTC:PGWFF
|
NZ |
|
T
|
Tullow Oil PLC
XBER:TQW
|
UK |
|
MetalQuest Mining Inc
F:E7Q
|
CA |
|
Z
|
Zemaitijos Pienas AB
SWB:IU8
|
LT |
|
Andrew Peller Ltd
OTC:ADWPF
|
CA |
|
D
|
Daldrup & Soehne AG
XMUN:4DS
|
DE |
|
Westgold Resources Ltd
F:0W2
|
AU |
|
S
|
Stoneridge Inc
F:2GX
|
US |
|
C
|
Compagnia Immobiliare Azionaria SpA
XBER:IAZ
|
IT |
|
B
|
Bella Casa Fashion & Retail Ltd
NSE:BELLACASA
|
IN |
Wall St Price Targets
IVBXF Price Targets Summary
Innovent Biologics Inc
According to Wall Street analysts, the average 1-year price target for IVBXF is 15.95 USD with a low forecast of 11.89 USD and a high forecast of 19.66 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IVBXF's stock price target?
Price Target
15.95
USD
According to Wall Street analysts, the average 1-year price target for IVBXF is 15.95 USD with a low forecast of 11.89 USD and a high forecast of 19.66 USD.
What is the Revenue forecast for Innovent Biologics Inc?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Revenue has been 127%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Innovent Biologics Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 8 years is 20%.
What is the Operating Income forecast for Innovent Biologics Inc?
Projected CAGR
44%
The compound annual growth rate for Operating Income over the next 8 years is 44%.
What is the Pre-Tax Income forecast for Innovent Biologics Inc?
Projected CAGR
89%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 89%.
What is the Net Income forecast for Innovent Biologics Inc?
Projected CAGR
36%
The compound annual growth rate for Net Income over the next 8 years is 36%.
